Brief: NanoRepro Enters Market For Diabetes Diagnostics

NanoRepro AG

13/04/2022 06:08

April 13 (Reuters) - NanoRepro AG  NN6G.DE :
    * ENTERS BILLION-DOLLAR OLIGOPOLY MARKET FOR DIABETES
DIAGNOSTICS
    * LICENSE AGREEMENT WITH EYESENSE FOR CONTINUOUS GLUCOSE
MONITORING SYSTEM (CGM)
    * MARKET LAUNCH IS PLANNED BY PLANNED BY 2024 AT THE LATEST
    * CONTRACT HAS A TERM OF UP TO 15 YEARS
    * HAS SECURED DISTRIBUTION RIGHTS IN THE EU AS WELL AS THE
SIX
ARAB STATES OF THE GULF COOPERATION COUNCIL (GCC), SUCH AS SAUDI
ARABIA, KUWAIT AND QATAR

Source text for Eikon:  ID:nEQ1hf3NDa 
Further company coverage:  NN6G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))